Long-term outcome in patients with follicular lymphoma following high-dose therapy and autologous stem cell transplantation.

Bernd MetznerChristiane PottThomas H MüllerJochen CasperChristoph KimmichEduard K PetershofenAndrea RenzelmannBernd RosienRuth TholeAndreas VoßClaus Henning KöhneDominique Wellnitz

Published in: European journal of haematology (2021)

Sustained long-term clinical and molecular complete remissions up to 27 years can be achieved following ASCT (including HDT with BEAM in second treatment line), indicating a potential curative impact of ASCT in FL.

Keyphrases

high dose
stem cell transplantation
low dose
bone marrow
rectal cancer
replacement therapy
monte carlo
mesenchymal stem cells
climate change